Bristol-Myers gets EU approval for diabetes drug
Monday, October 5, 2009 - 12:21
in Health & Medicine
(AP) -- Drugmaker Bristol-Myers Squibb Co. said Monday that its new diabetes drug, Onglyza, has been approved for sale in the European Union's 27 countries.